Taken together, in this focused proteomic analysis guided by a whole transcriptomic approach, we identified VEGFA, TGFB1, and CSF1 as novel proteins whose circulating levels were reduced by tesamorelin in association with a decline in NAFLD severity among PLWH with NAFLD. The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatotic liver disease.